Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001851416-25-000010
Filing Date
2025-05-08
Accepted
2025-05-08 11:41:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7631
  Complete submission text file 0001851416-25-000010.txt   9513
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Subject) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-88872 | Film No.: 25924811
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 303 E WACKER DRIVE SUITE 1040 CHICAGO IL 60601
Business Address 303 E WACKER DRIVE SUITE 1040 CHICAGO IL 60601 312-297-7000
Streeterville Capital LLC (Filed by) CIK: 0001851416 (see all company filings)

EIN.: 852954598 | State of Incorp.: UT | Fiscal Year End: 1231
Type: SCHEDULE 13G